Clovis Oncology

Clovis Oncology is a small pharmaceutical company which mainly markets products for treatment in oncology.[1] Depomed was founded in 2009 and is headquartered in Dover, Colorado.[2] The company is a publicly traded company on NASDAQ under the symbol "CLVS" [3] and is in the NASDAQ Biotechnology Index[4] with several products in its product pipeline.[5]

Pipeline

Its products include:

Rociletinib

It is developing rociletinib,[6] which is in development as a treatment for non-small cell lung cancer.[1][7][8][9]

A phase III trial has completed and in April 2016 an FDA committee will consider recommending it for marketing approval.[10] If approved it would compete with AstraZeneca's Tagrisso (osimertinib).[10]

Rucaparib

Rucaparib is a PARP inhibitor in Phase II and III clinical trials for advanced ovarian cancer.[11]

Lucitanib

Lucitanib is a VEGFR inhibitor.[12]

References

  1. 1 2 "Clovis Oncology: A Winning Or Losing Lottery Ticket?". Forbes. 2015-11-16. Retrieved 2016-01-04.
  2. ↑ "CLVS Profile". finance.yahoo.com.
  3. ↑ "Clovis Oncology Inc.". www.marketwatch.com. Retrieved 4 January 2016.
  4. ↑ "Overview NBI". nasdaq.com. Retrieved 4 January 2016.
  5. ↑ "Clovis Oncology - Products & Companion Diagnostics". Clovisoncology.com. 9 March 2015. Archived from the original on March 9, 2015. Retrieved 4 January 2016.
  6. ↑ Williams, Sean (23 December 2015). "A Festivus for the Invest in Us -- It's Time for the Airing of Grievances". Fox Business. Retrieved 4 January 2016.
  7. ↑ Wallace, Alicia. "Clovis Oncology stock bludgeoned after delay in cancer drug approval". www.denverpost.com. Retrieved 4 January 2016.
  8. ↑ "hClovis Oncology Announces Regulatory Update for Rociletinib NDA Filing". www.reuters.com. Retrieved 4 January 2016.
  9. ↑ "FDA Requests Additional Data for Rociletinib in EGFR T790M-Mutant NSCLC". OncLive. 2015-11-16. Retrieved 2016-01-04.
  10. 1 2 Investors doubt efficacy of Clovis lung cancer med rociletinib, shares off 11%. April 2016
  11. ↑ Rucaparib at Clovis
  12. ↑ Lucitanib at Clovis
This article is issued from Wikipedia - version of the Wednesday, April 06, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.